Europe Mass Spectrometry Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Europe Mass Spectrometry Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The Europe mass spectroscopy market is expected to register a CAGR of 6.5% over the forecast period.

Mass spectroscopy devices are mainly used in research and development activities in different industrial areas such as pharmaceuticals, life sciences, food, and others. As there were lockdown restrictions around the world due to the COVID-19 pandemic, these activities were negatively impacted and thus affected the mass spectrometry market. Mass spectrometry devices were used in the detection and analysis of COVID-19 samples which had a considerable positive impact on the market studied. For instance, an article by a journal, namely Healthcare in Europe, published in November 2020, mentioned that the United Kingdom biotech laboratory used mass spectroscopy in an approach to Coronavirus testing. In addition, MAP Sciences developed a gargle test, which collects samples from the back of the throat, and avoids the unpleasant sensation of the PCR swab tests. From there, the sample is tested for COVID testing mass spectroscopy with high levels of accuracy. Thus COVID-19 had a mixed impact on the growth of the market during the pandemic period. However, currently, the market has reached its pre-pandemic state in terms of the use of mass spectroscopy devices and is expected to witness healthy growth over the forecast period.

Key factors propelling the market growth include technological advancements and increased pharmaceutical and biotechnological compounds in the pipeline. Technological advancements in mass spectrometry are enabling new product launches from key players. For instance, in June 2022, Shimadzu introduced new mass spectrometers in the global market. Additionally, in June 2022, Agilent Technologies Inc. announced new LC/MS and GC/MS quadrupole mass spectrometers in the global market. The Agilent 6475 triple quadrupole LC/MS system, 5977C GC/MSD, plus the 7000E GC/TQ and the 7010C GC/TQ represent the latest revolution in Agilent’s 50-plus year history in mass spectrometry.

In addition, in April 2021, bioMérieux, a French company, announced the CE-marking of the new MALDI-TOF mass spectrometry identification system, VITEK MS PRIME, in the European market. With the new launch of mass spectrometry by key European companies such as bioMerieux and Agilent Technologies, the market studied is believed to witness strong growth in coming years.

Thus the above-mentioned factors are expected to drive the demand during the forecast period in Europe. However, the lack of skilled technicians and the high cost of mass spectrometry equipment are restraining the market growth.

Triple Quadrupole mass spectrometry devices are currently in high demand due to their wide applications and ease of use. Conventional hospital diagnostic assays are based on clinical chemistry and immunoassay techniques that require analyte-specific reagents and antibodies. The combination of liquid chromatography and tandem mass spectrometry allows unequivocal identification of traces of antibiotics and antibacterial agents in complex biological matrices. The increasing research in genetics, especially proteomics and the application of Tandem MS for the same, is propelling the growth of the market. The tandem mass spectrometry market has immense opportunities in various industries for several applications, like environmental water sampling (detection of contaminants, pesticides), clinical diagnostics, etc.

With the technological advancement in mass spectrometry and other analytics techniques, the key companies in the market are coming up with new product launches, which is one of the factors responsible for the growth of the segment. For instance, in June 2022, Agilent Technologies Inc. revealed its Agilent 6475 triple quadrupole LC/MS system along with another instrument at the 70th ASMS Conference on Mass Spectrometry and Allied Topics, and as per the company, the Agilent 6475 triple quadrupole LC/MS system is the next evolution in a sensitive, rugged, robust mass spectrometer. The 6475 incorporates intelligent reflex, an automated sample reinjection function that intelligently ‘reflexes’ to specific analysis conditions providing immediate validation of results, further improving the speed of analysis and reducing operator involvement

Hence, from the abovementioned factors, the Triple Quadrupole mass spectrometer is expected to witness healthy growth over the forecast period. High investment in the research and development activities by pharmaceutical and biotechnology companies and new technological advancements in mass spectrometer devices will also boost the growth of the studied market during the forecast period.

Germany holds a major share in the mass spectrometry market and is expected to show a similar trend over the forecast period mainly due to the increased funding for mass spectrometry, research and development activities related to mass spectrometry, widespread usage of mass spectrometer instruments in the life sciences, and the presence of key market players in the region. According to the data from OECD published in November 2022, the R&D spending in Germany was around USD 7,382.9 per capita. The high R&D expenditure indicates increased spending on crucial technologies such as mass spectrometry.

Additionally, the strategic activities of the key market players are expected to drive the growth of the studied market in Germany. For instance, in August 2021, the Organic Mass Spectroscopy team at Thermo Fisher Scientific Bremen, Germany, took initiative for a sustainable future in mass spectroscopy and announced the ambitious IsoFootprint Project. The IsoFootprint Project is an initiative to remove all CO2 emissions associated with the manufacturing and production of all new instruments. Such initiatives are expected to contribute to the growth of the market over the forecast period in Germany.

In September 2021, the first Net Zero Mass Spectrometer was launched to Support Greener Future in Germany. The Thermo Scientific Delta Q Isotope Ratio Mass Spectrometer (IRMS) is a next-generation gas IRMS designed to enable detailed analysis with greater precision and accuracy. Thus, owing to the above factors, the market is expected to grow in Germany during the forecast period.

Key players in the market are focusing on the development of their product portfolios, acquisition of emerging players, and distribution agreements to increase their geographical presence. Some of the key firms dominating the market are Agilent Technologies Inc., Danaher Corporation, Perkinelmer Inc., Thermo Fisher Scientific Inc., Bruker Corporation, Waters Corporation, Shimadzu Corporation, Leco Corporation, and Dani Instruments SpA.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support